Most biologic responses to IL-2 have been attributed to interaction of IL-2 with a high affinity receptor which consists of a heterodimer composed of two distinct IL-2-binding proteins (IL-2R alpha/IL-2R beta). However, both low affinity IL-2R alpha (55 kD) and intermediate affinity IL-2R beta (70-75 kD) also appear to be expressed independently on the cell surface. We investigated the receptor-specific regulatory effects of IL-2 on cytokine production in unstimulated and activated T cells. T cells were activated by stimulation of the antigen receptor complex with anti-CD3 mAb. IL-2 (10(2) U/ml, 1 nM) stimulation of resting cells resulted in a fivefold increase in GM-CSF release but in only minimal IFN-gamma release. IL-2 markedly augmented mRNA expression of GM-CSF but not IFN-gamma in unstimulated T cells. IL-2R beta mAb but not IL-2R alpha mAb decreased IL-2-induced GM-CSF release and mRNA expression from unstimulated T cells. IL-2 concentrations required for GM-CSF release from resting cells suggested ligand binding to an intermediate affinity receptor. GM-CSF and IFN-gamma release from activated T cells increased four- to fivefold in response to 1 nM IL-2 and IL-2 augmented both GM-CSF and IFN-gamma mRNA. IL-2R beta mAb but not IL-2R alpha mAb reduced GM-CSF release and mRNA expression in activated T cells stimulated with 1 nM IL-2. IL-2R alpha blockade markedly decreased IL-2-induced IFN-gamma release and mRNA expression from activated cells, while IL-2R beta blockade had little effect on IFN-gamma production in activated cells. IL-2R alpha blockade altered the affinity of the receptor mediating activated cell GM-CSF release from a high affinity to an intermediate affinity state. These studies indicate an independent role for IL-2R beta in mediating GM-CSF production from T cells. They also suggest that unstimulated and activated T cells, which express distinct IL-2 receptor moieties, mediate release of separate lymphokines and that different subunits of the IL-2 receptor may play an important role in the regulation of cytokine production.
S Burdach, N Zessack, D Dilloo, M Shatsky, D Thompson, L Levitt
Title and authors | Publication | Year |
---|---|---|
Efficacy and antitumor activity of a mutant type of interleukin 2.
Dehghan R, Beig Parikhani A, Zeinali S, Shokrgozar M, Amanzadeh A, Ajdary S, Ahangari Cohan R, Talebkhan Y, Behdani M |
Scientific Reports | 2022 |
Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1: Immune cells regulate VEGF signalling
T Hoeres, M Wilhelm, M Smetak, E Holzmann, G Schulze-Tanzil, J Birkmann |
Clinical & Experimental Immunology | 2018 |
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
FJ Hartmann, M Khademi, J Aram, S Ammann, I Kockum, C Constantinescu, B Gran, F Piehl, T Olsson, L Codarri, B Becher |
Nature Communications | 2014 |
CD25 Blockade protects T Cells from Activation-induced Cell Death (AICD) via Maintenance of TOSO Expression
GH Richter, A Mollweide, K Hanewinkel, C Zobywalski, S Burdach |
Scandinavian Journal of Immunology | 2009 |
Multiple Sclerosis
W Kim, HJ Kim |
Journal of the Korean Medical Association | 2009 |
Chemokines and Cancer
K Flanagan, HL Kaufman |
Cancer Investigation | 2002 |
Transplantation in Hematology and Oncology
WE Berdel, T Büchner, J Kienast, JV Loo, H Jürgens, J Ritter, J Vormoor |
2000 | |
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression
U Dirksen, R Nishinakamura, P Groneck, U Hattenhorst, L Nogee, R Murray, S Burdach |
Journal of Clinical Investigation | 1997 |
Interleukin-2 and human immunodeficiency virus infection: Pathogenic mechanisms and potential for immunologic enhancement
A Kinter, AS Fauci |
Immunologic Research | 1996 |
Activation of the HIV Type 1 Long Terminal Repeat by X-Irradiation Involves Two Main Rel/NF-κB DNA-Binding Complexes
E Faure, P Lecine, J Imbert, S Champion |
AIDS Research and Human Retroviruses | 1996 |
Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta
M Kruger, SV Gool, XH Peng, L Coorevits, MC Daele, JL Ceuppens |
Immunology | 1996 |
Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study
SE Burdach, M Müschenich, W Josephs, J Frisch, G Schulz, H Jürgens, U Göbel |
Cancer | 1995 |
Differential inhibition of lymphokine-activated killing, proliferation, and cytokine secretion by humanized antibodies against the low- and intermediate-affinity interleukin-2 receptors
KM Heaton, EA Grimm |
Human Immunology | 1995 |
Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells
R Zambello, L Trentin, A Cerutti, C Enthammer, A Milani, T Franceschi, C Messina, GL Cetto, C Agostini, G Semenzato |
Cancer | 1994 |
Endogenous Production and Peripheral Blood Levels of Granulocyte-Macrophage (GM - ) and Granulocyte (G - ) Colony-Stimulating Factors
B Sallerfors |
Leukemia & Lymphoma | 1994 |
Purification and characterization of a multicomponent AP-1.junD complex from T cells. Dependence on a separate cellular factor for enhanced DNA binding activity
K Gardner, TC Moore, T Davis-Smyth, H Krutzsch, D Levens |
The Journal of biological chemistry | 1994 |
Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle
T Mattern, S Ansorge, HD Flad, AJ Ulmer |
Immunobiology | 1993 |
Alpha-interferon enhances gamma-interferon production of peripheral blood mononuclear cells pre-activated with phytohemagglutinin
K Katayama, N Hayashi, T Takehara, K Suzuki, A Kasahara, H Fusamoto, T Kamada |
Gastroenterologia Japonica | 1993 |
The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features
G Semenzato, G Pizzolo, R Zambello |
International Journal of Clinical & Laboratory Research | 1992 |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays
B Sallerfors, T Olofsson |
European Journal of Haematology | 1992 |
Molecular regulation of hematopoietic cytokines: Implications and indications for clinical use in pediatric oncology
S Burdach |
Medical and Pediatric Oncology | 1992 |
Hexadecylphosphocholine induces interferon-γ secretion and expression of GM-CSF mRNA in human mononuclear cells
CH Hochhuth, K Vehmeyer, H Eibl, C Unger |
Cellular Immunology | 1992 |
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro
G Pizzolo, C Vincenzi, F Vinante, A Rigo, D Veneri, M Chilosi, S Dusi, G Poli, R Zambello, G Semenzato, G Berton |
Cellular Immunology | 1992 |
The response of human decidual leukocytes to IL-2
A King, R Wheeler, NP Carter, DP Francis, YW Loke |
Cellular Immunology | 1992 |
Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers
K Katayama, N Hayashi, T Takehara, T Towata, A Kasahara, H Fusamoto, T Kamada |
Journal of Clinical Immunology | 1992 |
Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis FACTOR-α, and INTERFERON-γ in two human cytotoxic leukemic T-cell lines
A Cesano, D Santoli |
In Vitro Cellular & Developmental Biology – Animal | 1992 |